Kraig Biocraft Laboratories, Inc.
KBLB· OTC
KBLBKraig Biocraft Laboratories, Inc.
Filed Nov 13, 2023 · 10-Q · 44 days after period end · 0001493152-23-040575
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Net Income | -$549.27K | -$810.36K | -$3.19M | -$693.16K |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
ended Sep 30, 2023 · filed Nov 13, 2023 · 44 d after period end
